Published ahead of print on January 21, 2005, doi:10.1164/rccm.200407-981OC
Am. J. Respir. Crit. Care Med., Volume 171, Number 8, April 2005, 858-867
A more recent version of this article appeared on April 15, 2005
Submitted on August 1, 2004
Accepted on January 15, 2005
Inhibition of the Src and Jak Kinases Protects Against Lipopolysaccharide-induced Acute Lung Injury
Mariano Severgnini1, Satoe Takahashi1, Powen Tu1, George Perides2, Robert J Homer3, Jhung W Jhung4, Deepa Bhavsar5, Brent H Cochran5, and Amy R Simon1*
1 Pulmonary and Critical Care Division, Tufts-New England Medical Center, Boston, MA, USA; Department of Physiology, Tufts University School of Medicine, Boston, MA, USA,
2 Department of Surgery, Tufts-New England Medical Center, Boston, MA, USA,
3 Department of Pathology, Yale University School of Medicine, New Haven, CT, USA,
4 Department of Pathology, Brown University School of Medicine, Providence, RI, USA,
5 Department of Physiology, Tufts University School of Medicine, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: amy.simon{at}tufts.edu.
The cascade of cellular and molecular pathways mediating acute lung injury are complex and incompletely defined. Although the Src and Jak family of kinases are upregulated in lipopolysaccharide-induced murine lung injury, their role in the development of lung injury is unknown. Here we report that systemic inhibition of these kinases using specific small molecule inhibitors (PP2,SU6656,TyrphostinA1) significantly attenuated lipopolysaccharide-induced lung injury, as determined by histologic and capillary permeability assays. These inhibitors blocked lipopolysaccharide-dependent cytokine and chemokine production in the lung and systemically. In contrast, lung-targeted inhibition of these kinases in the airway epithelium via adenoviral mediated gene transfer of dominant negative Src or of suppressor of cytokine signaling (SOCS-1) disrupted lung cytokine production, but had no effect on systemic cytokine production or lung vascular permeability. Mice were significantly protected from lethal lipopolysaccharide challenge by the small molecule inhibitors of Jak and Src kinase. Importantly, this protection was still evident even when the inhibitors were administered 6 hours post-lipopolysaccharide challenge. Taken together, these observations suggest that Jak and Src kinases participate in acute lung injury and verify the potential of this class of selective tyrosine kinase inhibitors to serve as novel therapeutic agents for this disease.
Key words: Acute Lung Injury, Src Kinase, Jak Kinase, Signal Transducers and Activators of Transcription, Lipopolysaccharide
This article has been cited by other articles:

|
 |

|
 |
 
R. D. Ramnath, J. Sun, and M. Bhatia
Involvement of Src Family Kinases in Substance P-Induced Chemokine Production in Mouse Pancreatic Acinar Cells and Its Significance in Acute Pancreatitis
J. Pharmacol. Exp. Ther.,
May 1, 2009;
329(2):
418 - 428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chopra, J. S. Reuben, and A. C. Sharma
Acute Lung Injury:Apoptosis and Signaling Mechanisms
Experimental Biology and Medicine,
April 1, 2009;
234(4):
361 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gong, D. J. Angelini, S. Yang, G. Xia, A. S. Cross, D. Mann, D. D. Bannerman, S. N. Vogel, and S. E. Goldblum
TLR4 Signaling Is Coupled to SRC Family Kinase Activation, Tyrosine Phosphorylation of Zonula Adherens Proteins, and Opening of the Paracellular Pathway in Human Lung Microvascular Endothelia
J. Biol. Chem.,
May 9, 2008;
283(19):
13437 - 13449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chatterjee, C. Snead, G. Yetik-Anacak, G. Antonova, J. Zeng, and J. D. Catravas
Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability
Am J Physiol Lung Cell Mol Physiol,
April 1, 2008;
294(4):
L755 - L763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Lee, C. Moon, H. W. Lee, E.-M. Park, M.-S. Cho, and J. L. Kang
Src Tyrosine Kinases Mediate Activations of NF-{kappa}B and Integrin Signal during Lipopolysaccharide-Induced Acute Lung Injury
J. Immunol.,
November 15, 2007;
179(10):
7001 - 7011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chatterjee, C. Dimitropoulou, F. Drakopanayiotakis, G. Antonova, C. Snead, J. Cannon, R. C. Venema, and J. D. Catravas
Heat Shock Protein 90 Inhibitors Prolong Survival, Attenuate Inflammation, and Reduce Lung Injury in Murine Sepsis
Am. J. Respir. Crit. Care Med.,
October 1, 2007;
176(7):
667 - 675.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Simeone-Penney, M. Severgnini, P. Tu, R. J. Homer, T. J. Mariani, L. Cohn, and A. R. Simon
Airway Epithelial STAT3 Is Required for Allergic Inflammation in a Murine Model of Asthma
J. Immunol.,
May 15, 2007;
178(10):
6191 - 6199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Okutani, M. Lodyga, B. Han, and M. Liu
Src protein tyrosine kinase family and acute inflammatory responses
Am J Physiol Lung Cell Mol Physiol,
August 1, 2006;
291(2):
L129 - L141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in critical care 2005.
Am. J. Respir. Crit. Care Med.,
April 15, 2006;
173(8):
833 - 841.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|